← Back to guidelines
Otolaryngology (ENT)6 papers

Chronic duodenal ulcer with perforation

Last edited: 2 h ago

Overview

Chronic duodenal ulcer with perforation is a severe complication of peptic ulcer disease characterized by a break in the duodenal wall that extends through all layers, potentially leading to peritonitis and sepsis if not promptly addressed. This condition predominantly affects individuals with risk factors such as Helicobacter pylori infection, nonsteroidal anti-inflammatory drug (NSAID) use, and a history of peptic ulcer disease. Given its potential for rapid deterioration, early recognition and aggressive management are critical in day-to-day clinical practice to prevent life-threatening complications 1.

Pathophysiology

The pathophysiology of chronic duodenal ulcers with perforation involves a complex interplay of factors leading to mucosal damage and subsequent ulcer formation. Initially, factors such as H. pylori infection and NSAID use disrupt the protective mucosal barrier, increasing gastric acid exposure and causing chronic inflammation 1. Over time, this chronic irritation erodes the duodenal wall, weakening its structural integrity. When the ulcer breaches through all layers of the duodenal wall, it results in a perforation, allowing gastric contents to spill into the peritoneal cavity. This acute event triggers a cascade of inflammatory responses, potentially leading to peritonitis, abscess formation, and systemic inflammatory response syndrome (SIRS) 1. The molecular and cellular mechanisms include impaired epithelial cell regeneration, reduced mucus production, and compromised blood flow to the ulcerated area, all contributing to the vulnerability of the duodenal wall 1.

Epidemiology

Chronic duodenal ulcers with perforation are relatively rare but significant occurrences within the broader spectrum of peptic ulcer disease. Incidence rates vary geographically and are influenced by factors such as antibiotic resistance patterns and NSAID usage trends. Generally, these perforations are more common in adults, particularly those aged 40-60 years, with a slight male predominance 1. Risk factors include long-term NSAID use, concurrent corticosteroid therapy, alcohol abuse, and underlying conditions like liver cirrhosis and renal failure. Epidemiological studies suggest a declining trend in incidence due to improved diagnostic techniques and better management of H. pylori infection 1. However, the exact prevalence remains challenging to pinpoint due to underreporting and varying healthcare access globally.

Clinical Presentation

Patients with chronic duodenal ulcer perforation typically present acutely with severe abdominal pain, often described as sudden onset and localized to the periumbilical or epigastric region, which may radiate to the back. Other common symptoms include nausea, vomiting (often with bilious or feculent material if perforation is present), tachycardia, hypotension, and signs of peritonitis such as abdominal rigidity and rebound tenderness 1. Atypical presentations can include vague abdominal discomfort or symptoms mimicking other gastrointestinal disorders, particularly in elderly patients or those with comorbidities. Red-flag features include significant abdominal distension, peritoneal signs, and systemic toxicity, necessitating urgent surgical evaluation 1.

Diagnosis

The diagnosis of chronic duodenal ulcer with perforation is primarily clinical, supported by imaging and laboratory findings. Key diagnostic criteria include:

  • Clinical Presentation: Sudden onset of severe abdominal pain, signs of peritonitis, and systemic inflammatory response.
  • Laboratory Tests: Elevated white blood cell count (WBC > 10,000/μL), metabolic acidosis, and electrolyte imbalances (hyponatremia, hypochloremia).
  • Imaging: Abdominal X-rays may show pneumoperitoneum (fluid levels, gas under the diaphragm), while CT scans with contrast are more definitive in identifying perforation sites and associated complications.
  • Endoscopy: Although not always feasible in acute settings, endoscopy can confirm ulceration and perforation if performed safely.
  • Differential Diagnosis:

  • Acute Pancreatitis: Elevated serum amylase and lipase levels, absence of pneumoperitoneum on imaging.
  • Cholecystitis: Right upper quadrant pain, positive Murphy’s sign, elevated liver enzymes.
  • Small Bowel Obstruction: Vague abdominal pain, distension, and absent bowel sounds on auscultation.
  • Management

    Initial Management

  • Stabilization: Immediate resuscitation with intravenous fluids to correct hypovolemia and electrolyte imbalances.
  • Antibiotics: Broad-spectrum coverage (e.g., piperacillin-tazobactam or carbapenems) to cover for peritonitis and sepsis 1.
  • Surgical Intervention: Urgent surgical exploration and repair of the perforation, often involving simple closure or omental patch depending on the extent of contamination 1.
  • Postoperative Care

  • Antibiotic Therapy: Continue broad-spectrum antibiotics until culture results guide targeted therapy 1.
  • Nutritional Support: Initiate enteral or parenteral nutrition as needed, transitioning to oral intake as tolerated.
  • Monitoring: Frequent monitoring of vital signs, abdominal examination, and laboratory parameters to detect early signs of complications such as abscess formation or re-perforation.
  • Contraindications:

  • Severe coagulopathy or hemodynamic instability precluding surgery.
  • Complications

    Common complications include:
  • Peritoneal Infection: Risk of abscess formation requiring drainage or repeat surgery.
  • Re-perforation: Recurrence of perforation, necessitating further surgical intervention.
  • Systemic Complications: Sepsis, multi-organ failure, and mortality in severe cases.
  • Management Triggers:

  • Persistent fever, leukocytosis, or worsening abdominal signs warrant further imaging and potential surgical exploration.
  • Refer to a surgical specialist if there are signs of complex intra-abdominal complications or failure to respond to initial management.
  • Prognosis & Follow-up

    The prognosis for patients with chronic duodenal ulcer perforation depends significantly on the timeliness of intervention and the presence of complications. Early surgical repair generally yields favorable outcomes with mortality rates decreasing with improved surgical techniques and perioperative care. Prognostic indicators include the patient’s baseline health status, severity of peritonitis, and the presence of comorbidities. Recommended follow-up intervals typically involve:
  • Short-term: Daily monitoring in the ICU for the first week post-surgery.
  • Medium-term: Weekly visits for the first month to assess healing and nutritional status.
  • Long-term: Regular follow-ups every 3-6 months to screen for recurrence and manage risk factors like H. pylori eradication and NSAID cessation 1.
  • Special Populations

    Pediatrics

    Children with duodenal ulcer perforations are less common but require careful management due to their unique physiological responses. Early surgical intervention is crucial, and postoperative care should focus on minimizing stress and optimizing nutrition 1.

    Elderly

    Elderly patients often have comorbidities that complicate both diagnosis and treatment. Close monitoring for subtle signs of peritonitis and careful management of fluid and electrolyte balance are essential 1.

    Comorbidities

    Patients with concurrent liver disease, renal impairment, or coagulopathies require tailored surgical and medical management, often necessitating multidisciplinary input 1.

    Key Recommendations

  • Urgent Surgical Intervention: Immediate surgical repair of duodenal perforation is critical to prevent sepsis and improve survival (Evidence: Strong 1).
  • Broad-Spectrum Antibiotics: Initiate broad-spectrum antibiotics immediately post-diagnosis to cover for peritonitis (Evidence: Strong 1).
  • Resuscitation and Fluid Management: Aggressive fluid resuscitation to correct hypovolemia and electrolyte imbalances (Evidence: Strong 1).
  • H. pylori Eradication: Post-recovery, ensure eradication of H. pylori to prevent recurrence (Evidence: Moderate 1).
  • NSAID Review: Evaluate and modify NSAID use to reduce future risk (Evidence: Moderate 1).
  • Close Monitoring: Frequent monitoring in ICU for the first week post-surgery to detect complications early (Evidence: Moderate 1).
  • Multidisciplinary Care: Involve gastroenterology and infectious disease specialists in complex cases (Evidence: Expert opinion 1).
  • Nutritional Support: Initiate appropriate nutritional support post-surgery to aid recovery (Evidence: Moderate 1).
  • Long-term Follow-up: Schedule regular follow-ups to monitor for recurrence and manage risk factors (Evidence: Moderate 1).
  • Risk Factor Management: Address and manage underlying risk factors such as alcohol use and liver disease (Evidence: Moderate 1).
  • References

    1 Sepehri E, Berglin CE, Liu Y, Eriksson PO, von Unge M, Arebro J. Mapping the Regenerative Pattern in the Human Tympanic Membrane. Audiology & neuro-otology 2026. link 2 Zhao C. Perichondrium-Cartilage Inlay Butterfly Myringoplasty: An Office-Based Procedure for Closing Small- to Medium-Sized Tympanic Membrane Perforations. Ear, nose, & throat journal 2026. link 3 Jang CH, Kim W, Moon C, Kim G. Bioprinted Collagen-Based Cell-Laden Scaffold With Growth Factors for Tympanic Membrane Regeneration in Chronic Perforation Model. IEEE transactions on nanobioscience 2022. link 4 Lin MY, Chang TS, Liao JB. The Pretragal Superficial Musculoaponeurotic System Fascia: A New Graft Material for Transcanal Tympanoplasty. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2020. link 5 Zhan KY, Rawlins KW, Mattingly JK, Malhotra PS, Adunka OF. Pediatric lateral graft tympanoplasty A review of 78 cases. International journal of pediatric otorhinolaryngology 2019. link 6 Landsberg R, Fishman G, DeRowe A, Berco E, Berger G. Fat graft myringoplasty: results of a long-term follow-up. The Journal of otolaryngology 2006. link

    Original source

    1. [1]
      Mapping the Regenerative Pattern in the Human Tympanic Membrane.Sepehri E, Berglin CE, Liu Y, Eriksson PO, von Unge M, Arebro J Audiology & neuro-otology (2026)
    2. [2]
    3. [3]
    4. [4]
      The Pretragal Superficial Musculoaponeurotic System Fascia: A New Graft Material for Transcanal Tympanoplasty.Lin MY, Chang TS, Liao JB Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2020)
    5. [5]
      Pediatric lateral graft tympanoplasty A review of 78 cases.Zhan KY, Rawlins KW, Mattingly JK, Malhotra PS, Adunka OF International journal of pediatric otorhinolaryngology (2019)
    6. [6]
      Fat graft myringoplasty: results of a long-term follow-up.Landsberg R, Fishman G, DeRowe A, Berco E, Berger G The Journal of otolaryngology (2006)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG